March 23, 2016
(Sci Dev Net) – A promising vaccine candidate to protect against dengue fever is undergoing a clinical trial in Brazil and could result in a new vaccine next year. The TV003 vaccine candidate was shown to fully protect against DENV-2, a strain of the dengue virus against which there are currently no safeguards. “During an earlier trial of the proposed vaccine, the United States National Institutes of Health gave a small group of adult volunteers the vaccine which is a mixture of weakened forms of all four dengue strains.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.